<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Prospective Grant of Start-Up Exclusive Evaluation Option License Agreement: AAV Mediated Aquaporin-1 Gene Transfer To Treat Sjögren's Syndrome</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Prospective Grant of Start-Up Exclusive Evaluation Option License Agreement: AAV Mediated Aquaporin-1 Gene Transfer To Treat Sjögren's Syndrome</h1>
    <p class="timestamp">Published: 2014-07-09 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>This is notice, in accordance with 35 U.S.C. 209 and 37 CFR part 404, that the National Institutes of Health (NIH), Department of Health and Human Services (HHS), is contemplating the grant of a Start- Up Exclusive Evaluation Option License Agreement to Milo, LLC, a company having its headquarters in Cleveland, Ohio, to practice the inventions embodied in U.S. Provisional Patent Application No. 61/ 695,753, filed 20 April 2011 (HHS Ref. No. E-139-2011/1-US-01]), and PCT Patent Application No. PC...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, National Institutes of Health</p>
    <p><strong>Document Number:</strong> 2014-16030</p>
    <p><strong>Publication Date:</strong> 2014-07-09</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2014/07/09/2014-16030/prospective-grant-of-start-up-exclusive-evaluation-option-license-agreement-aav-mediated-aquaporin-1">https://www.federalregister.gov/documents/2014/07/09/2014-16030/prospective-grant-of-start-up-exclusive-evaluation-option-license-agreement-aav-mediated-aquaporin-1</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2014-16030</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
